Free Access
Med Sci (Paris)
Volume 24, Number 3, Mars 2008
Page(s) 317 - 319
Section Repères
Published online 15 March 2008
  1. Jordan B. Chroniques génomiques. Des puces ADN en clinique ? Med Sci (Paris) 2007; 23 : 210–4. [Google Scholar]
  2. Figarella-Branger D, Colin C, Chinot O, et al. Tumorothèque de l’AP-HM : cartographie moléculaire des gliomes. Med Sci (Paris) 2006; 22 (suppl 1) : 54–9. [Google Scholar]
  3. Jardin F, Tilly H. Un saut (de puce) vers une application clinique des profils d’expression génique dans les lymphomes. Med Sci (Paris) 2004; 20 : 848–50. [Google Scholar]
  4. Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 2005; 365 : 176–86. [Google Scholar]
  5. Michiels S, Koscielny S, Hill C. Interpretation of microarray data in cancer. Br J Cancer 2007; 96 : 1155–8. [Google Scholar]
  6. Van ’t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415 : 530–6. [Google Scholar]
  7. Pawitan Y, Michiels S, Koscielny S, et al. False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics 2005; 21 : 3017–24. [Google Scholar]
  8. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005; 365 : 488–92. [Google Scholar]
  9. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 2006; 103 : 5923–8. [Google Scholar]
  10. Ransohoff DF. Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 2005; 5 : 142–9. [Google Scholar]
  11. Van de Vijver MJ, He YD, van’t Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347 : 1999–2009. [Google Scholar]
  12. Buyse M, Loi S, van’t Veer L, et al. Transbig consortium. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006; 98 : 1183–92. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.